Drugs / gp145 C.6980
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03382418 | Dec 2017 → Sep 2019 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp145 C.6980 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03382418 ↗ |
| Modality | Vaccine | “an HIV vaccine (gp145 C.6980)” NCT03382418 ↗ |